PL352374A1 - Inhibitors of integrine o v beta 6 - Google Patents
Inhibitors of integrine o v beta 6Info
- Publication number
- PL352374A1 PL352374A1 PL00352374A PL35237400A PL352374A1 PL 352374 A1 PL352374 A1 PL 352374A1 PL 00352374 A PL00352374 A PL 00352374A PL 35237400 A PL35237400 A PL 35237400A PL 352374 A1 PL352374 A1 PL 352374A1
- Authority
- PL
- Poland
- Prior art keywords
- integrine
- inhibitors
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19929410A DE19929410A1 (en) | 1999-06-26 | 1999-06-26 | New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis |
PCT/EP2000/005404 WO2001000660A1 (en) | 1999-06-26 | 2000-06-13 | INHIBITORS OF THE INTEGRIN αvβ¿6? |
Publications (1)
Publication Number | Publication Date |
---|---|
PL352374A1 true PL352374A1 (en) | 2003-08-25 |
Family
ID=7912712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00352374A PL352374A1 (en) | 1999-06-26 | 2000-06-13 | Inhibitors of integrine o v beta 6 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1189930A1 (en) |
JP (1) | JP2003503422A (en) |
KR (1) | KR20020015704A (en) |
CN (1) | CN1358195A (en) |
AR (1) | AR024472A1 (en) |
AU (1) | AU771099B2 (en) |
BR (1) | BR0011954A (en) |
CA (1) | CA2377224A1 (en) |
CZ (1) | CZ20014484A3 (en) |
DE (1) | DE19929410A1 (en) |
HU (1) | HUP0201729A3 (en) |
MX (1) | MXPA01013247A (en) |
NO (1) | NO20016341L (en) |
PL (1) | PL352374A1 (en) |
SK (1) | SK18722001A3 (en) |
WO (1) | WO2001000660A1 (en) |
ZA (1) | ZA200200673B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
JP2007523835A (en) | 2003-02-06 | 2007-08-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Peptidesulfonamide |
GB0520068D0 (en) * | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
ES2746925T3 (en) | 2006-08-03 | 2020-03-09 | Medimmune Ltd | Antibodies Directed Towards alfaVbeta6 and Use of Them |
ES2906109T3 (en) | 2016-11-01 | 2022-04-13 | Arrowhead Pharmaceuticals Inc | Alpha-v beta-6 integrin ligands and uses thereof |
EP3703700A4 (en) | 2017-11-01 | 2021-08-04 | Arrowhead Pharmaceuticals, Inc. | Integrin ligands and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2103139A1 (en) * | 1991-05-14 | 1992-11-15 | George A. Heavner | Peptide inhibitors of inflammation |
ATE511850T1 (en) * | 1997-08-08 | 2011-06-15 | Univ California | TREATMENT OF BLADDER FIBROSIS WITH ANTIBODIES TO ALPHA-V BETA-6 INTEGRIN |
CZ20012212A3 (en) * | 1998-12-19 | 2001-09-12 | Merck Patent Gmbh | Peptidic compound, use thereof and pharmaceutical preparation in which the compound is comprised |
-
1999
- 1999-06-26 DE DE19929410A patent/DE19929410A1/en not_active Withdrawn
-
2000
- 2000-06-13 MX MXPA01013247A patent/MXPA01013247A/en unknown
- 2000-06-13 AU AU62630/00A patent/AU771099B2/en not_active Ceased
- 2000-06-13 CA CA002377224A patent/CA2377224A1/en not_active Abandoned
- 2000-06-13 WO PCT/EP2000/005404 patent/WO2001000660A1/en not_active Application Discontinuation
- 2000-06-13 CN CN00809493A patent/CN1358195A/en active Pending
- 2000-06-13 BR BR0011954-7A patent/BR0011954A/en not_active IP Right Cessation
- 2000-06-13 CZ CZ20014484A patent/CZ20014484A3/en unknown
- 2000-06-13 PL PL00352374A patent/PL352374A1/en unknown
- 2000-06-13 HU HU0201729A patent/HUP0201729A3/en unknown
- 2000-06-13 SK SK1872-2001A patent/SK18722001A3/en unknown
- 2000-06-13 JP JP2001507066A patent/JP2003503422A/en active Pending
- 2000-06-13 EP EP00949177A patent/EP1189930A1/en not_active Withdrawn
- 2000-06-13 KR KR1020017016580A patent/KR20020015704A/en not_active Application Discontinuation
- 2000-06-23 AR ARP000103177A patent/AR024472A1/en not_active Application Discontinuation
-
2001
- 2001-12-21 NO NO20016341A patent/NO20016341L/en not_active Application Discontinuation
-
2002
- 2002-01-24 ZA ZA200200673A patent/ZA200200673B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20016341D0 (en) | 2001-12-21 |
BR0011954A (en) | 2002-05-07 |
EP1189930A1 (en) | 2002-03-27 |
CN1358195A (en) | 2002-07-10 |
CA2377224A1 (en) | 2001-01-04 |
MXPA01013247A (en) | 2002-07-02 |
CZ20014484A3 (en) | 2002-04-17 |
KR20020015704A (en) | 2002-02-28 |
SK18722001A3 (en) | 2002-05-09 |
AU6263000A (en) | 2001-01-31 |
DE19929410A1 (en) | 2000-12-28 |
HUP0201729A2 (en) | 2002-08-28 |
HUP0201729A3 (en) | 2005-01-28 |
AU771099B2 (en) | 2004-03-11 |
WO2001000660A1 (en) | 2001-01-04 |
AR024472A1 (en) | 2002-10-02 |
NO20016341L (en) | 2002-02-25 |
ZA200200673B (en) | 2003-04-24 |
JP2003503422A (en) | 2003-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141445A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
EG24291A (en) | Novel form of s-omeprazole | |
GB9900416D0 (en) | Inhibitors | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
GB0024805D0 (en) | Amide derivatives as beta 3 agonists | |
PL335378A1 (en) | Derivatives of inverse hydroxamates as metaloprotease inhibitors | |
PL337827A1 (en) | Bactericidal derivatives of n-sulphoglycin alkynyloxyphenethylamide | |
HK1039124B (en) | Phthalzaine derivatives phosphodiesterase 4 inhibitors | |
PL339176A1 (en) | Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase | |
IL141446A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
EP1093373A4 (en) | OLIGONUCLEOTIDE INHIBITORS OF bcl-xL | |
HK1042695A1 (en) | Prothease inhibitors | |
PL352374A1 (en) | Inhibitors of integrine o v beta 6 | |
PL339186A1 (en) | Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase | |
PL352409A1 (en) | Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane | |
PL350963A1 (en) | Use of arylalkanoylpyridazines | |
HK1051033A1 (en) | Inhibitors of interleukin 5 gene expression | |
HUP0201610A3 (en) | Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin | |
GB9904070D0 (en) | Inhibition of scale | |
GB9827817D0 (en) | Type 11 Dehydroquinase inhibitors | |
AU143545S (en) | Set of screws | |
HU9900075V0 (en) | Sepulchre consists of elements | |
GB9917294D0 (en) | Inhibitors | |
GB9929341D0 (en) | Inhibitors |